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group,arterialocclusionwas determinedmacroscopicellyaftersacrifice.
f?esukare showninthe table.Comparedwithcontrolvessels(Gr. 11),ar-
terieswithconjugate-immobilisedstents(Gr. 1)hadsignificantlyIessaplatelet
deposition(P= 0.0003), fewer episodesof bCFV (P= 0.0011), highermean
C2-hourflow (P = 0.0002) and significantlyhigherarterialpatency‘rates (P
= 0.027).
Corrc/usion:Platelet-tSrgetSdurokinaeepassivelyimmobilisedtopolymer-
coetedstentemarkedlyreducestheirthrombogenicity.Suchdevicesmaybe
particularlyuaefulforanticoagulant-freestentinginsmallvessela. orforbailout
stentingand meritfurtherevaluation.
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n7715 A New Biodegradable Polylectic Acid CoronaryStent-Coating, Releasing PEG-Hirudin and a
Prostacycline Analog, Reduces Both Platelet
Activation and Plasmatic Coagulation
G.Schmidmaier, A. Stemberger1, E. Alt, M. Gawaz, F.-J.Neumann,
A. Sch6mig.1.Med. Klinik, Inst. for Exp. Surgery Germany 1 Tahnische
Universit.4tMOnchen,Germany
Experiencewithcoronarystentinghasdemonstratadthatadhesionofplasma
proteinsto the metallicstentsurfaceand plateletactivationlimitthe implant
effeotivenesaby meansof acuteand subacutethrombosis.We investigated
a new stentcoatingof polylacticacid (PLA) carrier(25 kDa) containing5%
polyethyleneglycol-hirudinand 1% prostacyclinanalog(PG12).Methods:7
mm metallicatents (n = 46) were tested coated vs uncoatedin a human
atasis model with the non-anticoagulatacfblood of healthy volunteers. After
5 min thrombusweight,aPTT, markersof”acfivatedcoagulation(thrombin-
antithrombin-complexesTAT 01and prothmmbinfragmentaF1–2), mllagen
inducedplateletaggregationand CD62p/CD4i expressionwere measured
andscanningelectronmicroacopyperformed.Ffesults:Uncoatedstentswere
completelycovered by a coagulationplug rich in fibrinand platelets.The
costed stents were practically free from thrombotic material.
Controlwithoutstent Uncoatedstent Coated etent
Thrombua(mg) 2.02 * 0.50”” 0.02+0.01
aPIT (sac) 29.87 *2.54 29,60 + 2.35** 58.7759.24
TAT 01(pmol/1) 5.92 +0.S4 25.52 A 4.45** 6.03+ 1.13
FI-2 lnmolll) 0.94+0.07 2.14+0.33** 0.99* 6.06
Piat~l~t”Agg~eg. (%) 92.13*4.24 90.62 *4.34*” 10.53* 0.33
AcDs2p 10.0s * 0.66 12.63 + 1.S4” 11.73+ 0.62
CD41a 146.56 + 5.S7 lS2.S3&4.78” 21.43+3.22
*P< 0.05,**P <0.001, Coatedvs uncOated Stent
Conclusion.’ Our results show that PIA stent coating releasing PEG-
hirudinandaprostacyclinanaloghasa significanteffectonbothplateletacti-
vationand plasmaticcoagulation,therebypreventingstentinducedthrombus
formation.
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m771 6 High-Shear Overridea the Antithrombotic Effects of
Aspirin on Stent Thrombosis
R. Makkar,F. Litvack,S. Kaul,H. Zeng, N. Eigler.Cedars-Sinai Medical
Center, Los Angeles, CA, USA
Shear at stent surfacea is affected by vessel size, blood flow, pre-existing
thrombusand adSCfuaCYofstentdeployment. Wetestedthe effiCSCYofaSPirin
(10 or 20 mg/kg iv) at different blood shear rates. Unpolished nitinol stents
(n= 46) were expanded to a diameter of 2 mm in a perfuaion chamber and
exposed to flowing arterial blood (n = 6 pigs) for 20 minutes in a porcine
arteriovenous shunt model of stent thrombosis. Shear was regulated by
altering the blood flow. Stent thrombosis was quantified by measuring dry
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thrombus weight. Data are mean + sd. Arachidonic acid (540 mM)-induced
Dlatelet aggregation was inhibited by 48 +5% (P < 0.01) and bleedin9 time
was mild~-pr;longed (360 * 50 vs. 200 + 30”secs; p = ns) with ASA 10
mg/kg. Higher doses of aspirin (20 mg/kg) simiiarly failed to inhibit ST (17 +
2 vs 19+ 1 mg for control, n =6; p = ns) at the highest shear.
Conclusion: ASA inhibits stent thrombosis at low but not at high shear
rates. In high-risk clinical situations characterized by high blood shear, ASA
alone may not provide sufficient antiplatelet activity.
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1772-1I predictor~ofsuccesaand~~jor~omPl,~ationsfor
Primary PTCA in Acute Myocardial Infarction
E.D. Grassman, S.A. Johnson, R.J. Krone. Loyo/a University Medical
Centec Maywood, IL, USA, Washington UniveraiV, St. Louis, MO, USA
Primaryangioplastyhas recentlybeen advocatedas a safe and moreeffec-
tivetreatmentthanthrombolytictherapyforacutemyocardialinfarction(AMI).
The Socieiy for Cardiac Angiography and Interventions (SCA&l) maintains
a regist~ for diagnostic and intetventional procedures. Primary angioplasty
for AMI in the laboratories contributing to the registw was reviewed, and
predictors of successful PTCA, in-hospital mortality, and emergency CABG
were identified. 4,366 PTCA procedures were performed for AMI without
prior thrombolytic therapy among 78,199 PTCA’S (5.6%). Lab volume, age,
sex, symptoms, intreaotiic balloon pump (IABP) use, prior AMI, prior CABG,
diabetes, hypertension, shock, moribund state, CHF, and prior PTCA of the
same aitewereanalyzed. The overall success rate was 91.5%, the in-hospital
morkelifyrate was 2.5%, and the rate of emergency CABG was 3.&’o. These
are all similar to other published series. Higher PTCA volume and lower age
wera predictive of successful PTCA using multivariable logistic regression
analysis, while an IABP in place, shock, and moribund state had negative
predictive effects (p< 0.05). Unsuccessful PTCA, shock, and moribund state
were predictive of in-hospital death (p < 0.05). Unsuccessful PTCA, the ab-
sence of hypertension,and absence of CHF were predictiveof emergency
CABG (p < 0.05).
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1772-21Nine-yearoutcomeofpatiente”nder~oin9
Percutaneous Transluminal Coronary Angioplaety
for Acute Myocardial Infarction: Repo~ from the
1985-1986 NHLBI PTCA Regiatry
S.T. Lee, D.O. Williams, C.R. Cannan, K.E. Kip, S.F. Kelsey, K.M. Detre.
Rhode /s/and Hospital, Brown University Providence, RI, USA
Percutaneoustransluminal coronatyangioplasty (PTCA)isan effeofivemeans
of achieving reperfusion in patients with acute myocardial infarction, but the
long-term outcome of this therapy is unknown. Accordingly, we foilowed the
clinical status of 1320 consecutive PTCA patients without history of Ml (no
Ml), 619 patients with Ml >30 days prior to PTCA (remote Ml), 373 patients
with Ml 46 hours to 30 days prior to PTCA (recent Ml), and 119 patients
with Ml within 46 hours of PTCA (acute Ml). The in-hospital mortalities were
no Ml 0.8Y0, remote Ml 1.0%, recent Ml 1.9%, and acute Ml 9.2% (p <
0.001). After a median of 9.0 years of follow-up, the risk of subsequent Ml or
bypass surgery did not differ by pre-procedural Ml,status with the exception
that acute Ml patients had less repeat PTCA (20.9$’.) than the other three
groups (range 31.5%-42.7%, p < 0.01). Crude nine-year mortality, however,
was higheat in the acute Ml patients (41.8Yo)when compared with recent
Ml (22.8%), remote Ml (25.1%), and no Ml patients (17.9%, p c 0.001).
After adjusted multivariate analysis, Ml within 48 hours of PTCA remained an
independent predictor of nine-year mortality (relative risk= 1.75, p c 0.01).
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In this study, patients having emergent PTCA for AMI had poorer in-
hospital and long-term prognosis. Additional efforts directed at improving
outcome in these patients are warranted.
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Time to Treatment Influences Recovery of Left
Ventricular Function Following Successful Primary
Angioplasty in Patiente With AcuterMyocardial
Infarction
1.Sheiban, G.M.C. Rosano, S. Tonni, G. Vicadomini, A. Margonato,
S.L. Chierchia. Dept. of Cardiolow Istituto .Werrfifico H San Rar7ae/e,
Milano-Roma, Italy
Prima~ coronary angioplasty (PTCA) for acute myocsrdial infarction (AMI)
limits infarct size and preserves left ventricular function (LVF). Aim of the
present study was to evaluate the importance of time to treatment on the
recoveryof LVFin 102consecutive pts (70% men, 30% women, mean age 58
+8yeara) undergoing primav PTCAbecause of AMI. Coronary angiography
and left ventriculography were performed on admission as well as 24 hours
and 6 months after PTCA. Serial echocerdiograms were obtained on admis-
sion and 1,3,7,30,90 and 180 daya after procedure. LVglobale systolic and
diastolic function parameters, as well as, regional wall motion were evaluated
by qualitative methods on all serial ventricograms and echocardiograms. 85
pts had a complete follow-up studies and represents the population of the
present study. Pts were allocated into 3 groups according to the time from
symptom onset to PTCA: <2 hours (18 pts, Group A), 2 to 4 hours (32 pts,
Group S), >4 hours (35 pts, Group C) Clinical and angiografic characteristics
and infarct site were similar in the 3 pts groups. Procedural succesa was
100%. Pts of Group A and Bshowed a significant and progressive recovery
of LVF between day 7 and day 180 (p < 0.01) while no significant difference
in LVF was notad between day 1 and day 7 (p= NS). In these pts no signif-
icant relation was found between the degree of LVF recovery and the peak
of cardiac enzymes release during the acute phase. LVF recovery was not
notad on follow-up ventricolograms and echocadiograms in pts of Group C(p
= NS). Intheae patienta the degree of LVdysfunction was significantly related
to peak cardiac enzymes release (r = ... p c 0.01). Restenosia occurred in
21 pte (24%) but had no impact on LVF unless it caused total occlusion. In
conclusion, pts undergoing primary PTCA for AMI have a good recovery of
LVF if treated early (<4 hours). In these pts there is a progressive recovery
of LVF during the first 3 months from PTCA.
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~{ ThelnfluenceofMYocardial,nfarctionAfier
Angioplasty on in-Hoepital and Long-Term Survival
W.S. Weintraub, Y. Shen, N. Chronos, R. Karstela, J.S. Douglas, Jr.,
Z.M.B. Ghszzal, S.B. King Ill. &nory University At/anta, GA, USA
We explored the influence of a myocardial infarction (Ml) after PTCAdefinad
es CPK elevation to >3 times the upper limit of normal, a new Q wave or
the composite. CPK elevation occurred in 1949 or 18,505 patients (11.8%)
and new Q waves in 196 (1.2%). In-hospital mortality was 0.17Y0without
a CPK elevation and 1.74% with a CPK elevation (p < 0.0001). In-hospital
mortality was 0.29% without a new Q wave and 5.6% with a new Q wave (p
< 0.0001). Multivariate correlates of in-hospital death were older age (odds
1.075 per year, P= O.0001),emergent status (odds 5.2, p =0.0001), elevated
CPK (odds 5.0, p = 0.0001), in-hospital CABG (odds 4.5, p =0.0003), aevere
angina (odds 3.5, p = 0.034), new Q wave (odds 3.1, p = 0.013), diabetes
(colds2.5, p= 0.0019), 3vessel disease (odds 2.1, p = 0.014) and first PTCA
(odds 2.1, p = 0.035. The 6 year survival without was 85% vs 79% with a
CPK elevation (see Fig.).
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Six-yearsutvivalwee84%without vs79% with anew Q wave (p= O.013).
The multivariate correlates of late death are older age (HR 1.05 per year, p
= 0.0001), diabetes (HR 1.9, p = 0.0001), prior coronary surgery (HR 1.6, p
= 0.0001), severe angina (hazard ratio 1.5, p = 0.0001), new Q wave (HR
1.5, p = 0.056), CPK elevation (HR 1.3, p = 0.0001), prior Ml (HR 1.4, p =
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0.0001), hypertension (HR 1.33, p = 0,0001), 3 vessel disease (HR 1.25, p =
0.0016), and emergent procedure (hazard ratio 1.20, p = 0.044).
Myocerdial infarction, including CPK elevation in the absence of new Q
waves, isaserious complication of angioplasty, with immediate and long-term
adverse consequences.
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1772-5]Latec rdi~~EventsAfierLowLeve,~re tine
Kmaes Elevation With “Uncomplicated” Coronary
Intervention - Why Is There a Risk and How Large Is
It?
S.G.Ellis, G.L. Howell, G. Popp. C/eve/and C/irricFourrdafion, C/eve/and,
OH, USA
Creatine kinase (CK) elevation >3x normal after PTCA is associated with
excess late cardiac risk. Low Ievela (LL) of CK elevation may also be aeeo-
ciatad with an increase in late cardiac events, especially death. It is unclear
if this is a causative relation-perhaps inducing CHF, arrhythmia (A), an asso-
ciation via diffuse coronaty disease with Ml or simply a correlation for which
regression techniques have not adjusted. If the risk is via CHF or A, one
might expect a graded risk of LL CK and larger ML We studied 3000 con-
secutively treated patients (pts) to ascertain the relation of CK 1-3x normal
with MB > 4%, and late events, adjusting for several variables not acmunted
for in many prior reports on this topic. 70 pts (2.3%) were excluded due to
in-hospital death or emergency CABG. Mean follow-up was 20 + 6 mos. 24
mo suwival and event-free survival were 95.5% and 78.8%.
CardiacDeath Ml PTCA or CA6G
OR p AOR p OR p AOR p OR p AOR p
LL CK (n = 231) 1.5 0.09 1.2 NS 2.1* 0.07 1.9 0.10 0.9 NS 0.9 NS
Non QMI > 3x’ 2.4 0.03 1.7 0.11 4.5 0.02 3.4 0.05 1.3 NS 1,2 NS
orQMl (n = 59)
OR= oddsratio,AOR = adjuatedOR, “3.50/. va 1.6% at 24 mos
Thus, 1) excess risk after LL CK rise is largely that of late Ml and possibly
a small incremental risk of cardiac death; 2) risk of cardiac death is attenuated
after adjustment for other variables; 3) the incremental risk of Ml maybe due
to a correlation of extent of disease and risk of both procedural and late Ml,
or other factors.
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1772-61 lncreseedAPoPtotic ActivitY inHuman Coronary
Atherectomy Samples From Patients With Unstable
vs. Stable Angina
G. Bauriedel, R. Hutter, S. Schluckebier, B. Ltideritz, U. Welsch,
M.F. Prescott. Dept. of Cardiology UrriversityofBonn, Dept. of Anatomy,
University of Munich, Gerrrrary CVFfesearch, Ciba Pharma, Summit, NJ,
USA
Acute coronary syndromes are thought to be caused by erosion or rupture
of the plaque fibrous cap. Apoptosis may play an important role in these
events. We therefore compared coronary atherectomy samples from patients
with unstable vs. stable angina. Cellular composition, apoptotic events and
necroses were quantitated (x+ SD) using transmission electron microscopy.
Determinant Unateble (n = 9) Stable [n= 9) D value
Cell density(celIs/mm2)
SMCakells (%)
Macrophages(M)/cells (“A)
Lymphocyteskella(“A)
ApoptoticSMCs/cells (%)
Apoptotic.Wcella(“A)
Apoptoticbodies4cslls
Necroasskells
345 * 194
52 +24
15 *23
5*1O
23&8
5&8
1.8 + 0.5
0.2i 0.1
236 +41
75& 24
7&11
3*8
13*7
2&3
1.1 + 0.4
0.2+0.1
0.16
0.14
0.41
0.14
0.05
0.34
0.02
0.4s
Celluiarcomposition differad between groups, whereas number of necroeas
did not. Early and late stages of apoptosis were both significantly higher in
unstable vs. stable angina. Apoptotic bodies were found extra- and intre-
cellularfy in about 20% of nearby macrophages as well as smooth muscle
cells (SMCS), signaling phagocytosis of both ceil types. Our date suggest
that apoptosis is a critical event in the biology of unstable angina. To miti-
gate the apoptotic machine~ andlorto increase the phagocytotic capacity of
neighboring cells may be attractive therapeutic targets.
